ETAMSYLATE & TRANEXAMIC ACID

VIBEMSYL T

COMPOSITION
ETAMSYLATE250MG
TRANEXAMIC ACID250MG
SPECIFICATION
FORMTABLET
PACKING10×10
PACKING TYPEALU ALU
MRP

DESCRIPTION

Tranexamic Acid

Antifibrinolytic hemostatic used in severe hemorrhage.

SIDE EFFECTS

Tranexamic Acid

Oral LD<sub>50</sub> in mice is >10 gm/kg. Symptoms of overdosage may be nausea, vomiting, orthostatic symptoms and/or hypotension.

INDICATION

TRANEXAMIC ACID

For use in patients with hemophilia for short term use (two to eight days) to reduce or prevent hemorrhage and reduce the need for replacement therapy during and following tooth extraction. It can also be used for excessive bleeding in menstruation, surgery, or trauma cases.